N-methyl-d-aspartate receptors: Structure, function, and role in organophosphorus compound poisoning

Dora Kolić1, Zrinka Kovarik1,2

  • 1Division of Toxicology, Institute for Medical Research and Occupational Health, Zagreb, Croatia.

PubMed

Insights

Organophosphorus compound poisoning causes seizures by overstimulating brain receptors. Inhibiting N-methyl-d-aspartate receptors (NMDARs) can prevent neurotoxicity and inflammation, offering new therapeutic strategies.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Acute organophosphorus compound (OP) poisoning leads to cholinergic crises and severe epileptic seizures.
  • Seizures result from cholinergic hyperstimulation, exacerbated by glutamatergic system hyperactivity.
  • Elevated acetylcholine overstimulates muscarinic receptors, causing neuronal hyperexcitation and calcium influx via N-methyl-d-aspartate receptors (NMDARs).

Purpose of the Study:

  • To review the detrimental role of NMDARs in OP-induced neurotoxicity.
  • To highlight the importance of NMDAR inhibition in mitigating OP neurotoxicity and inflammation.
  • To explore NMDAR inhibitors as potential therapeutics for OP poisoning.

Main Methods:

  • Review of existing literature on NMDAR structure and function.
  • Analysis of NMDAR involvement in OP poisoning mechanisms.
  • Evaluation of NMDAR inhibition as a therapeutic strategy.

Main Results:

  • NMDARs play a central role in OP-induced excitotoxicity, oxidative stress, and neuroinflammation.
  • NMDAR overactivation contributes to recurrent seizures, neuronal death, and neurological damage.
  • NMDAR inhibition effectively suppresses neurotoxicity and modulates the inflammatory response.

Conclusions:

  • NMDARs are critical targets for preventing OP-induced neurotoxicity.
  • NMDAR inhibitors offer a promising therapeutic avenue for OP poisoning, addressing limitations of current treatments.
  • Targeting NMDARs may overcome pharmacoresistance and mitigate the proinflammatory response in OP poisoning.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
856
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
565
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.2K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
958
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
808